伏立诺他
MAPK/ERK通路
细胞生物学
p38丝裂原活化蛋白激酶
组蛋白脱乙酰酶抑制剂
细胞凋亡
癌症研究
信号转导
组蛋白脱乙酰基酶
激酶
蛋白激酶A
化学
生物
组蛋白
生物化学
基因
作者
Jenny Sun,Hsiuyi Tseng,Lian Xu,Zachary R. Hunter,Bryan Ciccarelli,Mariateresa Fulciniti,Bangmin Zhu,Kaveh Maghsoudi,Guang Yang,Ping Gong,Yangsheng Zhou,Xia Liu,Nikhil C. Munshi,Christopher J. Patterson,Steven P. Treon
标识
DOI:10.3109/10428194.2011.577850
摘要
Histone deacetylases (HDACs) are aberrantly expressed, and inhibitors of HDACs induce apoptosis in lymphoplasmacytic cells (LPCs) in Waldenström macroglobulinemia (WM). The molecular profile by which these agents induce apoptosis in WM LPCs remains to be delineated. We examined the activity of the histone deacetylase inhibitor, vorinostat, and dissected its pro-apoptotic pathways in WM LPCs. Vorinostat induced apoptosis in WM cells through activating specific caspases at varying times. Inhibitors of apoptosis (IAPs) were down-regulated after vorinostat treatment. Cellular stress induced in vorinostat-treated WM cells was reflected by changes in the mitogen activated protein kinase (MAPK) pathways. Activated phospho-p38 MAPK was up-regulated at 12 h, while phospho-extracellular signal-regulated kinase (Erk) abruptly decreased at 24 h. Bortezomib did not augment vorinostat induced primary WM cell killing as reported in other B-cell disorders. These studies support that stress induced apoptosis in vorinostat-treated WM LPCs is mediated through disrupting the activity of the Erk and p38 MAPK pathways.
科研通智能强力驱动
Strongly Powered by AbleSci AI